TIMP1 and cancer: Cancer cells can recruit CAFs to the TME by upregulating the expression of tissue inhibitors of metalloproteinases 1 (TIMP-1), which leads to increased CAF proliferation and migration by binding with CD63, its receptor on CAFs.